Mitochondrial dysfunction, oxidative stress and diabetic cardiovascular disorders.

Area of Science:

• Cardiovascular Science
• Metabolic Disorders
• Oxidative Stress Biology

Background:

• Diabetes mellitus prevalence is rising globally, with cardiovascular complications as a leading cause of mortality.
• The precise mechanisms linking diabetes to cardiovascular susceptibility are not fully understood.
• Elevated oxidative stress and mitochondrial dysfunction are observed in diabetic patients.

Purpose of the Study:

• To elucidate the role of oxidative stress in diabetes-associated cardiovascular complications.
• To investigate the contribution of mitochondrial dysfunction and NADPH oxidase (NOX) in diabetic vascular pathology.
• To explore potential therapeutic strategies for mitigating diabetes-induced oxidative stress.

Main Methods:

• Review of existing literature on diabetes, oxidative stress, and cardiovascular disease.
• Analysis of metabolic derangements in diabetes, including hyperglycemia and dyslipidemia.
• Examination of the impact of glycated/oxidized low-density lipoproteins (LDL) on endothelial cells and mitochondria.

Main Results:

• Diabetes-associated metabolic disorders contribute to increased reactive oxygen species (ROS) production.
• Impaired mitochondrial respiration and activated NADPH oxidase (NOX) exacerbate oxidative stress in vascular endothelial cells.
• Glycated/oxidized LDL negatively affects mitochondrial respiratory chain enzymes and promotes NOX activity.

Conclusions:

• Diabetes-induced metabolic disorders promote mitochondrial dysfunction, NOX activation, and excess ROS production, leading to oxidative stress.
• This oxidative stress significantly contributes to the development of cardiovascular complications in diabetic individuals.
• Statins, metformin, and anthocyanidins show potential in reducing diabetes-induced vascular oxidative stress.